title: [Descriptive analysis of patients admitted to hospital for acute cerebrovascular disease].
abstract: BACKGROUND
  Acute cerebrovascular disease (ACVA) makes up a high proportion of the neurological patients admitted to hospital, but we do not know the exact figures in our setting. We consider that it would be useful if the use of health-care resources for attending these patients was to be evaluated and studied by the neurologists who direct them.
  
  
  OBJECTIVE
  To analyze a predetermined series of variables related to strokes in our setting. Patients and methods. We made a descriptive analysis by means of a questionnaire, recording variables related to the admission to the neurology department of patients with probable ACVA, at 100 days and with further evaluation 6 months later.
  
  
  RESULTS
  We recorded 107 cases with ACVA confirmed in 101 of 104 patients with averages of: 70.54 years, average admission 13.53 days and intrahospital mortality 5.8%. The most common neurological findings were paralysis and speech disorder. The proportion of ischaemic stroke as compared with haemorrhagic stroke was 87.5% to 12.5%. The prevalence of usual risk factors was: arterial hypertension, diabetes and cardiopathy. The percentage of patients given rehabilitation treatment during their admission was 41.34%. A proportion, 37.2%, of the patients were referred to Hospital San Rafael for convalescence and treatment. The average time before evaluation by a neurologist was 30.23 hours. Eleven of 86 patients who answered a weekly questionnaire died (12.8%) and 54/86 had no rehabilitation treatment during the week (62.8%).
  
  
  CONCLUSIONS
  We found no differences in the epidemiological characteristics as compared with other studies. The excessive lapse of time before attending the emergency department was striking, as was the delay in receiving neurological attention since there was no emergency neurologist available and fewer haemorrhagic strokes since there was no neurosurgical service available. There was little use of salicylates as a platelet anti-aggregrant agent on discharge from hospital, little rehabilitation treatment six months after the stroke, and twice as much mortality as when the patients were in hospital. We consider that a more detailed and extensive analysis would be fully justified in our setting, preferably with more people interested in the early and late treatment of ACVA taking part and prolonged follow-up of these patients.
authors.affiliation: Servicio de Neurología; Hospital Clínico Universitario "San Cecilio", Granada, 18012, España.
authors.forename: F J
authors.initials: FJ
authors.lastname: Barrero
authors.forename: M J
authors.initials: MJ
authors.lastname: Gómez
authors.forename: J
authors.initials: J
authors.lastname: Gutiérrez
authors.forename: M I
authors.initials: MI
authors.lastname: López
authors.forename: A
authors.initials: A
authors.lastname: Casado
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D001037:Aphasia / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D001921:Brain / Q000098:blood supply; D002545:Brain Ischemia / Q000150:complications / Q000188:drug therapy / Q000534:rehabilitation*; D002560:Cerebrovascular Circulation / Q000502:physiology; D004632:Emergency Medical Services / Q000600:supply & distribution; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D010243:Paralysis / Q000453:epidemiology / Q000209:etiology / Q000534:rehabilitation; D010343:Patient Admission / Q000706:statistics & numerical data; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011446:Prospective Studies; D012307:Risk Factors; D011795:Surveys and Questionnaires; D013997:Time Factors
chemical_list: D010975:Platelet Aggregation Inhibitors